




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
EnglishRoundsF/17yoPMHx:nephroticsyndrome4monthHPI:Chestpainfor2weeks.Cough,hemoptysisfor6daysdyspneafor1dayPE:T38.3℃,HR148/min,RR34/min,BP138/72mmHg,SpO292%@RAJugularveindistention,1+edemaofbothlegsProminentP2,systolicmurmur(grade2/6)overtheleftlowersternalborderUCG:ModeraterightventriculardilatationFlattened,paradoxicalseptalmotionEstimatedpulmonaryarterysystolicpressure:60mmHgNormal:15-30mmHgPulmonaryHypertension?PulmonaryHypertension(PH)
DefinitionmPAP(mean
pulmonaryarterialpressure)
≥
25mmHgatrestechocardiography
or
rightheartcatheterization
ClassificationGroup
1-5Group1:PAH(pulmonaryarterialhypertension)
IdiopathicandheritablePAHDrugsandtoxinsConnectivetissuediseasesHIVPortalhypertensionCongenital
heart
diseaseSchistosomiasisPulmonaryveno-occlusivediseasepersistentpulmonaryhypertensionofthenewborn(PPHN)ClassificationGroup2:
PH(left
heart
disease)Systolic
dysfunctionDiastolic
dysfunctionValvular
heart
diseaseInflow/outflow
tract
obstructionCongenital
cardiomyopathyClassificationGroup3:
PH(lung
disease)COPD(Chronic
obstructive
pulmonary
disease)ILD(Interstitial
lung
disease)CPFE(Combined
pulmonary
fibrosis
and
emphysema)Sleep
related
breathing
disorderClassificationGroup4:
PH
(thromboembolic
disease)Group5:
PH(multifactorial)Hemolytic
anemiaMyeloproliferative
disordersSystemic
disorders(eg.sarcoidosis)epidemiologyPrevalence
of
Group
1:
0.5-1.5
cases/100,000Traditional
point:
women
of
childbearing
age.
Now:
all
age
groups,
all
racial
populations,
both
gendersPathogenesisGeorgOhmChangeinpressure
=
flow
x
resistancePpaPpvpathogenesisChangeinpressure
=
flow
x
resistancePpa-Ppv
=
Q
x
PVRPpa
=
(Q
x
PVR)
+
PpvPpa
=
(QxPVR)+PCWPPVR:pulmonary
vascular
resistancePCWP:
pulmonarycapillarywedgepressureLAP:
left
atrial
pressureLVEDP:
leftventricularend-diastolicpressurePCWPPpvLAPLVEDPpathogenesis??pulmonaryvascularresistanceVascular
problemsIdiopathic
PAHConnective
tissue
diseaseHIV
infectionDecreasetheareaofthepulmonaryvascularbedPulmonary
emboliInterstitial
lung
diseaseconditionsthatinducehypoxicvasoconstrictionHypoventilation
syndromesPathogenesisPathogenesis??flow:Congenital
heart
defects
with
left-right
shuntASDVSDPDA??pulmonary
venous
pressure(mainlyLHD)Mitral
valve
diseaseLeft
ventricular
systolic
or
diastolic
dysfunctionConstrictive
pericarditisRestrictive
cardiomyopathyPulmonary
venous
obstructionPathologySymptoms?output?exertionaldyspnealethargyfatigueRight
heart
failureExertionalchest
pain
(subendocardial
hypoperfusion)Peripheral
edema
(right
ventricular
failure)Anorexia
and
abdominal
pain
(liver
congestion)Alteredbioenergetics(ischaemia,mitochondrialremodelling)Neurohormonaland
immunologicalactivationPathophysiologyofRVdysfunctioninPAHVonk-NoordegraafA,etal.JAmCollCardiol2013;62:D22-33.PAHRVpressureoverload↑RVwallstressMyocardialremodellingHypertrophy;matrixremodellingIncreaseinRVcontractilityGeneticDeterminantsAdaptiveremodelling(minimallyalteredEes/Ea)Maladaptive
remodellingDilatationandfailureArrhythmiasIschaemiaEa:arterialelastance;Ees:ventricularelastance;RV:rightventricularRVanatomy:NormalversusPAHNormalPAHChinKM,etal.CoronArteryDis2005;16:13-8.LV120mmHgRVLVPRVThicknessStressCoronaryperfusionpressure+O2demand=Supply/DemandRVdistension&LVfilling=Cardiacoutput20mmHgLV:leftventricle/ventricular;RV:rightventricle/ventricularPhysical
examinationSplit
S2MurmurJugularveindistension:
prominent
A
waveEnlarged
liver
and
spleenDiagnosticevaluationChest
radiographElectrocardiographyEchocardiographyPulmonaryfunctiontestsV/QscanExercisetestingRightheartcatheterizationChest
radiography
Swan-GanzcatheterDiagnosticcriteria
(requiresrightheartcatheterization)PulmonaryhypertensionmPAP≥25mmHgPulmonaryarterialhypertensionMeanpulmonaryarterypressureis≥25mmHgatrestMeanpulmonarycapillarywedgepressure<15mmHg
ChroniclungdiseasesandothercausesofhypoxemiaaremildorabsentVenousthromboembolicdiseaseisabsentCertainmiscellaneousdisordersareabsentsystemicdisorders(eg,sarcoidosis)hematologicdisorders(eg,myeloproliferativediseasesmetabolicdisorders(eg,glycogenstoragedisease)26PAH的治療流程:循證醫(yī)學(xué)證據(jù)GalièN,etal.JAmCollCardiol2013;62:D60-72.
指導(dǎo)下運(yùn)動(dòng)(I-A)
心理-社會(huì)支持(I-C)避免過度體力勞動(dòng)(I-C)
避孕(I-C)流感和肺炎球菌疫苗接種(I-C)一般性治療和支持性治療口服抗凝:特發(fā)性PAH,遺傳性PAH及食欲抑制劑相關(guān)PAH(IIa-C)繼發(fā)性PAH(IIb-C)利尿劑(I-C)氧療(I-C)地高辛(IIb-C)專病轉(zhuǎn)診(I-C)急性血管擴(kuò)張?jiān)囼?yàn)
(特發(fā)性PAH:I-C)(繼發(fā)性PAH:IIb-C)開始PAH靶向藥物治療陰性FCI-IIICCB
(I-C)持續(xù)有效(FCI-II)繼續(xù)CCBNo陽(yáng)性YesCase1F/17yoPMHx:nephroticsyndrome4monthHPI:Chestpainfor2weeks.Cough,hemoptysisfor6daysDyspneafor1dayPE:T38.3℃,HR148/min,RR34/min,BP138/72mmHg,SpO292%@RAJugularveindistention,1+edemaofbothlegsProminentP2,systolicmurmur(grade2/6)overtheleftlowersternalborderUCG:pulmonaryarterysystolicpressureof60mmHgDidthepatienthaspulmonaryhypertension?Whatsymptomsandsignsmayindicatesuchcondition?Chestpain?Dyspnea?JugularveindistentionProminentP2Diagnostic:RHC,butnotstronglyindicatedbeforefurtherexaminationF/17yoPMHx:nephroticsyndrome4monthHPI:Chestpainfor2weeks.Cough,hemoptysisfor6daysDyspneafor1dayPE:T38.3℃,HR148/min,RR34/min,BP138/72mmHg,SpO292%@RAJugularveindistention,1+edemaofbothlegsProminentP2,systolicmurmur(grade2/6)overtheleftlowersternalborderUCG:pulmonaryarterysystolicpressureof60mmHgWhatarethepossibleunderlyingdiseasesofPHinthiscase?ComplicationsofNS?InfectionThrombosisARFAtherosclerosisElectrolytedisturbanceF/17yoPMHx:nephroticsyndrome4monthHPI:Chestpainfor2weeks.Cough,hemoptysisfor6daysDyspneafor1dayPE:T38.3℃,HR148/min,RR34/min,BP138/72mmHg,SpO292%@RAJugularveindistention,1+edemaofbothlegsProminentP2,systolicmurmur(grade2/6)overtheleftlowersternalborderUCG:pulmonaryarterysystolicpressureof60mmHgWhatarethepossibleunderlyingdiseaseofPHinthiscase?ComplicationsofNS?Thrombosis-pulmonaryembolism?Infection-pneumonia?Atherosclerosis-ACS?AthirdconditioncausingNSandPH?Autoimmune-SLE?ANCA-associatedvasculitis?F/17yoPMHx:nephroticsyndrome4monthHPI:Chestpainfor2weeks.Cough,hemoptysisfor6daysDyspneafor1dayPE:T38.3℃,HR148/min,RR34/min,BP138/72mmHg,SpO292%@RAJugularveindistention,1+edemaofbothlegsProminentP2,systolicmurmur(grade2/6)overtheleftlowersternalborderUCG:pulmonaryarterysystolicpressureof60mmHgHowtoproveorruleoutthesehypothesis?ComplicationsofNS?Thrombosis-pulmonaryembolism?Infection-pneumonia?Atherosclerosis-ACS?AthirdconditioncausingNSandPH?Autoimmune-SLE?ANCA-associatedvasculitis?F/17yoPMHx:nephroticsyndrome4monthHPI:Chestpainfor2weeks.Cough,hemoptysisfor6daysDyspneafor1dayPE:T38.3℃,HR148/min,RR34/min,BP138/72mmHg,SpO292%@RAJugularveindistention,1+edemaofbothlegsProminentP2,systolicmurmur(grade2/6)overtheleftlowersternalborderUCG:pulmonaryarterysystolicpressureof60mmHgHowtoproveorruleoutthesedisorders?Detailedmedicalhistory:ChestpainCough&HemoptysisDyspneaPedaledemaSymptomsassociatedwithautoimmunediseaseF/17yoPMHx:nephroticsyndrome4monthHPI:Chestpainfor2weeks.Cough,hemoptysisfor6daysDyspneafor1dayPE:T38.3℃,HR148/min,RR34/min,BP138/72mmHg,SpO292%@RAJugularveindistention,1+edemaofbothlegsProminentP2,systolicmurmur(grade2/6)overtheleftlowersternalborderUCG:pulmonaryarterysystolicpressureof60mmHgHowtoproveorruleoutthesedisorders?PulmonaryembolismABG,D-DimerCTPA,V/Q,BUSoflowerextremityPneumoniaCBC,PCT,sputumcultureChestX-ray,CTACSECG,Mb,CK-MB,cTnIAutoimmuneANA,dsDNA,ANCASupplementofhistoryChestPain:bilateral,exacerbatedbycoughinganddeepinspirationCough&Hemoptysis:whitishsputum,smallamountofbloodDyspneaUponexercisePedaledemapitting,sincetheonsetofNSSymptomsassociatedwithautoimmunediseasenegativeECG“SIQIIITIII”CBC16.212.310.3497ABGhypoxia,respiratoryalkalosisBloodbiochemistrySignificantdecreaseofalbuminMildelevationofNTpro-BNPCoagulationSignificantelevationofD-DimerAutoimmune:negativeCTPAIntraluminalthrombimainpulmonaryarteryrightpulmonaryarteryleftpulmonaryarterysegmentalpulmonaryarteriesbilaterallySmallbilateralpleuraleffusionsCTPA–reconstructionBilateral,peripheral,wedge-shapedopacitiesF/17yoPMHx:nephroticsyndrome4monthHPI:Chestpainfor2weeks.Cough,hemoptysisfor6daysDyspneafor1dayPE:T38.3℃,HR148/min,RR34/min,BP138/72mmHg,SpO292%@RAJugularveindistention,1+edemaofbothlegsProminentP2,systolicmurmur(grade2/6)overtheleftlowersternalborderUCG:pulmonaryarterysystolicpressureof60mmHgDiagnosis?PulmonaryembolisminthesettingofthenephroticsyndromeWhichgroupofPHdoesitbelongto?GroupIIIthromboembolicdiseaseCase2F/46yoTransferredtothishospitalbecauseofseverePHHPI:2monthsearlier:Proximal-muscleweakness,myalgia
Raynaud’sphenomenonMaculopapularrashoverneckandanteriorchestDyspnea1weeksearlier:CoughandnonpleuriticchestpainontherightPE:FinecracklesatbothlungbasesLoudP2,splitS2,rightS2Liver1cmbelowcostalmarginPhysicalExamination:Confluentareasoferythemaontheneck,chest,andupperarmsVsignPhysicalExamination:Reddish-purpleeruptionontheuppereyelidandswellingoftheeyelidHeliotropesignF/46yoTransferredtothishospitalbecauseofseverePHHPI:2monthsearlier:Proximal-muscleweakness,myalgiaRaynaud’sphenomenonMaculopapularrashoverneckandanteriorchestDyspnea1weeksearlier:CoughandnonpleuriticchestpainontherightPE:FinecracklesatbothlungbasesLoudP2,splitS2,rightS2Liver1cmbelowcostalmarginPhysicalExamination:Gottron’ssignMultipleerythematousontheextensorsurfaceofthejointsF/46yoTransferredtothishospitalbecauseofseverePHHPI:2monthsearlier:Proximal-muscleweakness,myalgia
Raynaud’sphenomenonMaculopapularrashoverneckandanteriorchestDyspnea1weeksearlier:CoughandnonpleuriticchestpainontherightPE:FinecracklesatbothlungbasesLoudP2,splitS2,rightS2Liver1cmbelowcostalmarginWhatsymptomsindicatetheseverePH?Non-pleuriticchestpainontherightsideLoudP2,splitS2,rightventricularS2Liver1cmbelowcostalmarginProgressivedyspnea?F/46yoTransferredtothishospitalbecauseofseverePHHPI:2monthsearlier:Proximal-muscleweakness,myalgia
Raynaud’sphenomenonMaculopapularrashoverneckandanteriorchestDyspnea1weeksearlier:CoughandnonpleuriticchestpainontherightPE:FinecracklesatbothlungbasesLoudP2,splitS2,rightS2Liver1cmbelowcostalmarginVsign,heliotropesign,Gottron’ssignWhatisthemostlikelydiseasethatcausePHinthispatient?Dermatomyositis(DM)IdiopathicinflammatorymyopathySymmetricproximalmuscleweakness,20%amyopathicCharacteristicskinmanifestations5-30%interstitiallungdiseaseF/46yoTransferredtothishospitalbecauseofseverePHHPI:2monthsearlier:Proximal-muscleweakness,myalgia
Raynaud’sphenomenonMaculopapularrashoverneckandanteriorchestDyspnea1weeksearlier:CoughandnonpleuriticchestpainontherightPE:FinecracklesatbothlungbasesLoudP2,splitS2,rightS2Liver1cmbelowcostalmarginVsign,heliotropesign,Gottron’ssignWhatisthemostlikelydiseasethatcausethePHinthispatient?InterstitiallungdiseaseinDMMaybemorecommoninpatientswithnormalCKAssociatedwithanti-Jo-1Antisynthetasesyndrome:myositis,ILD,polyarthritis,mechanic’shand,feverandRaynaudphenomenonF/46yoTransferredtothishospitalbecauseofseverePHHPI:2monthsearlier:Proximal-muscleweakness,myalgia
Raynaud’sphenomenonMaculopapularrashoverneckandanteriorchestDyspnea1weeksearlier:CoughandnonpleuriticchestpainontherightPE:FinecracklesatbothlungbasesLoudP2,splitS2,rightS2Liver1cmbelowcostalmarginVsign,heliotropesign,Gottron’ssignHowtofurtherprovethediagnosis?Dermatomyositis:SerumcreatinekinaseElectromyographyMusclebiopsyESR,CRP,ANA,RFMRIInterstitiallungdisease:
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 全球?qū)櫸锸袌?chǎng)洞察之泰國(guó)篇:本土與出口市場(chǎng)雙擴(kuò)張中國(guó)品牌布局正啟航402mb
- 彌漫性食管痙攣的臨床護(hù)理
- 2025年門診部年度工作總結(jié)模版
- 角弓反張的臨床護(hù)理
- 暑期招生美術(shù)培訓(xùn)方案大綱
- 圓錐曲線公式總結(jié)模版
- 高血壓防治與管理要點(diǎn)
- 四川省成都市溫江區(qū)第二區(qū)2025年數(shù)學(xué)七下期末質(zhì)量跟蹤監(jiān)視模擬試題含解析
- 護(hù)膚培訓(xùn)年終工作總結(jié)與展望
- 抗菌藥物培訓(xùn)考核試題及答案
- MT 181-1988煤礦井下用塑料管安全性能檢驗(yàn)規(guī)范
- GB/T 193-2003普通螺紋直徑與螺距系列
- 因納特工商管理綜合實(shí)訓(xùn)軟件V4.00
- 四議兩公開工作法課件
- 國(guó)有企業(yè)干部選拔任用條例
- 2022年保山數(shù)字產(chǎn)業(yè)發(fā)展有限責(zé)任公司招聘筆試題庫(kù)及答案解析
- 通用造價(jià)35kV~750kV線路(國(guó)網(wǎng))課件
- Unit 1 Lesson 1 Lifestyles 課件 高中英語新北師大版必修第一冊(cè)(2022-2023學(xué)年)
- 村級(jí)組織權(quán)力清單、責(zé)任清單和負(fù)面清單x
- DB33∕T 715-2018 公路泡沫瀝青冷再生路面設(shè)計(jì)與施工技術(shù)規(guī)范
- 高一化學(xué)第二學(xué)期期末考試試題
評(píng)論
0/150
提交評(píng)論